(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.48%) $79.38
(1.14%) $1.954
(0.79%) $2 329.30
(0.51%) $26.89
(1.37%) $968.00
(0.02%) $0.933
(-0.03%) $11.03
(-0.09%) $0.798
(0.27%) $93.51
Live Chart Being Loaded With Signals
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States...
Stats | |
---|---|
今日成交量 | 6 000.00 |
平均成交量 | 531 310 |
市值 | 178.52M |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.00400 ( 2013-05-27 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.20 |
ATR14 | HKD0 (0.00%) |
Tongfang Kontafarma 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Tongfang Kontafarma 财务报表
Annual | 2023 |
营收: | HKD809.11M |
毛利润: | HKD464.54M (57.41 %) |
EPS: | HKD-0.00520 |
FY | 2023 |
营收: | HKD809.11M |
毛利润: | HKD464.54M (57.41 %) |
EPS: | HKD-0.00520 |
FY | 2022 |
营收: | HKD894.06M |
毛利润: | HKD506.22M (56.62 %) |
EPS: | HKD-0.0197 |
FY | 2021 |
营收: | HKD961.09M |
毛利润: | HKD482.89M (50.24 %) |
EPS: | HKD-0.00270 |
Financial Reports:
No articles found.
Tongfang Kontafarma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.00400 | 2012-05-28 |
Last Dividend | HKD0.00400 | 2013-05-27 |
Next Dividend | HKD0 | N/A |
Payout Date | 2013-06-13 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.00800 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.16 | -- |
Div. Sustainability Score | 4.38 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 2.15 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2660.HK | Ex Dividend Knight | 2023-06-30 | Annually | 0 | 0.00% | |
1425.HK | Ex Dividend Junior | 2023-06-16 | Annually | 0 | 0.00% | |
0512.HK | Ex Dividend Knight | 2023-06-09 | Annually | 0 | 0.00% | |
6866.HK | Ex Dividend Junior | 2023-07-21 | Sporadic | 0 | 0.00% | |
1970.HK | Ex Dividend Knight | 2023-06-09 | Semi-Annually | 0 | 0.00% | |
0998.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
0107.HK | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% | |
3339.HK | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
1576.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
0604.HK | Ex Dividend Junior | 2023-06-02 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0356 | 1.500 | -0.713 | -1.069 | [0 - 0.5] |
returnOnAssetsTTM | -0.0250 | 1.200 | -0.835 | -1.002 | [0 - 0.3] |
returnOnEquityTTM | -0.0397 | 1.500 | -1.553 | -2.33 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.516 | 0.800 | 7.42 | 5.94 | [1 - 3] |
quickRatioTTM | 1.140 | 0.800 | 8.00 | 6.40 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0686 | -1.500 | 8.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -14.97 | 1.000 | -6.66 | -6.66 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.000422 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00431 | 2.00 | -0.00215 | -0.00431 | [0 - 20] |
debtEquityRatioTTM | 0.112 | -1.500 | 9.55 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.577 | 1.000 | 3.72 | 3.72 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.203 | 1.000 | -6.06 | -6.06 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0199 | 1.000 | -1.001 | -1.001 | [0.2 - 2] |
assetTurnoverTTM | 0.703 | 0.800 | 8.65 | 6.92 | [0.5 - 2] |
Total Score | 4.38 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -4.13 | 1.000 | -0.518 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0397 | 2.50 | -0.998 | -2.33 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00431 | 2.00 | -0.00144 | -0.00431 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.000422 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0436 | 1.500 | -3.62 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00194 | 1.000 | -2.45 | 0 | [0.1 - 0.5] |
Total Score | -0.0903 |
Tongfang Kontafarma
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。